Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × carmustine, poliferprosan 20 drug combination × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lambert-Eaton Myasthenic Syndrome 1 Hodgkin Disease 1 HIV Infections 1 Burkitt Lymphoma 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡